title: Inherited thrombophilias.
abstract: Many inherited thrombophilias have been detected and the pathophysiologic insight has increased tremendously during the last decades. Despite, however, the overwhelming observational evidence on the association between inherited thrombophilia and several women's health issues, including VTE, thus far the implications for clinical practice are uncertain. Although there is firm epidemiologic evidence that is helpful in counseling women who have inherited thrombophilia to prevent a first or recurrent VTE, the uncertainty is particularly present for women who have other pregnancy complications, such as recurrent pregnancy loss and pre-eclampsia. For this group, well-designed placebo-controlled trials to assess the harm-benefit ratio are urgently needed.
authors.affiliation: Academic Medical Center, F4-276, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
authors.forename: Michiel
authors.initials: M
authors.lastname: Coppens
authors.forename: Stef P
authors.initials: SP
authors.lastname: Kaandorp
authors.forename: Saskia
authors.initials: S
authors.lastname: Middeldorp
mesh_terms: D000026:Abortion, Habitual / Q000209:etiology / Q000517:prevention & control; D005260:Female; D006801:Humans; D042965:Methylenetetrahydrofolate Reductase (NADPH2) / Q000235:genetics; D009154:Mutation; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic; D019851:Thrombophilia / Q000145:classification / Q000453:epidemiology / Q000235:genetics* / Q000503:physiopathology; D020246:Venous Thrombosis / Q000517:prevention & control
chemical_list: D042965:Methylenetetrahydrofolate Reductase (NADPH2)